Experienced in Denys-Drash Syndrome (DDS)
Experienced in Denys-Drash Syndrome (DDS)
1740 W Taylor St, 
Chicago, IL 

Overview

Mary Schmidt is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Chicago, Illinois. Dr. Schmidt is rated as an Experienced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 43 peer reviewed articles and participating in 68 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 7 clinical trials in the study of Denys-Drash Syndrome (DDS).

Specialties
Pediatrics
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in IL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

1740 W Taylor St, Chicago, IL 60612

Additional Areas of Focus

Dr. Schmidt has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


68 Clinical Trials

A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
View 40 Less Clinical Trials
Similar Doctors
Experienced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
Experienced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
2300 N Childrens Plz # 30, 
Chicago, IL 
 (4.1 miles away)
Languages Spoken:
English

Yasmin Gosiengfiao is a Pediatric Hematologist Oncology provider in Chicago, Illinois. Dr. Gosiengfiao is rated as an Experienced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Denys-Drash Syndrome (DDS), and Teratoma of the Mediastinum.

Experienced in Denys-Drash Syndrome (DDS)
Pediatrics | Nephrology
Experienced in Denys-Drash Syndrome (DDS)
Pediatrics | Nephrology

Lurie Children's Medical Group Inc.

225 E Chicago Ave, Box 118, 
Chicago, IL 
 (3.1 miles away)
Languages Spoken:
English

Mahima Keswani is a Pediatrics specialist and a Nephrologist in Chicago, Illinois. Dr. Keswani is rated as an Advanced provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). Her top areas of expertise are Feingold Syndrome, Congenital Nephrotic Syndrome, Nephrotic Syndrome, and Secondary Peritonitis.

Experienced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
Experienced in Denys-Drash Syndrome (DDS)
Pediatric Hematology Oncology
2300 Childrens Plaza, Division Of Hematology/oncology Box 30, 
Chicago, IL 
 (4.1 miles away)
Languages Spoken:
English

David Walterhouse is a Pediatric Hematologist Oncology provider in Chicago, Illinois. Dr. Walterhouse is rated as a Distinguished provider by MediFind in the treatment of Denys-Drash Syndrome (DDS). His top areas of expertise are Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Osteosarcoma, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schmidt's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile